ダイトの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/03/09 | 3,420 | 3,490 | 3,380 | 3,395 | +30 | +0.9% | 29,800 |
2018/03/08 | 3,440 | 3,445 | 3,330 | 3,365 | -45 | -1.3% | 19,400 |
2018/03/07 | 3,460 | 3,510 | 3,400 | 3,410 | -60 | -1.7% | 31,700 |
2018/03/06 | 3,455 | 3,505 | 3,435 | 3,470 | +65 | +1.9% | 29,800 |
2018/03/05 | 3,500 | 3,540 | 3,380 | 3,405 | -60 | -1.7% | 43,300 |
2018/03/02 | 3,355 | 3,495 | 3,325 | 3,465 | +80 | +2.4% | 35,800 |
2018/03/01 | 3,515 | 3,525 | 3,370 | 3,385 | -140 | -4% | 62,500 |
2018/02/28 | 3,465 | 3,575 | 3,460 | 3,525 | +35 | +1% | 50,000 |
2018/02/27 | 3,580 | 3,595 | 3,460 | 3,490 | -55 | -1.6% | 21,300 |
2018/02/26 | 3,480 | 3,575 | 3,465 | 3,545 | +80 | +2.3% | 45,300 |
2018/02/23 | 3,510 | 3,530 | 3,460 | 3,465 | -10 | -0.3% | 15,100 |
2018/02/22 | 3,500 | 3,505 | 3,455 | 3,475 | +5 | +0.1% | 24,000 |
2018/02/21 | 3,500 | 3,500 | 3,430 | 3,470 | -15 | -0.4% | 32,700 |
2018/02/20 | 3,475 | 3,500 | 3,470 | 3,485 | +15 | +0.4% | 19,800 |
2018/02/19 | 3,345 | 3,485 | 3,345 | 3,470 | +125 | +3.7% | 31,900 |
2018/02/16 | 3,335 | 3,425 | 3,330 | 3,345 | +15 | +0.5% | 32,000 |
2018/02/15 | 3,360 | 3,375 | 3,280 | 3,330 | ±0 | ±0% | 40,200 |
2018/02/14 | 3,440 | 3,470 | 3,305 | 3,330 | -110 | -3.2% | 49,700 |
2018/02/13 | 3,535 | 3,550 | 3,400 | 3,440 | -85 | -2.4% | 53,600 |
2018/02/09 | 3,470 | 3,530 | 3,440 | 3,525 | -50 | -1.4% | 45,400 |
2018/02/08 | 3,660 | 3,780 | 3,570 | 3,575 | -45 | -1.2% | 72,100 |
2018/02/07 | 3,820 | 3,820 | 3,615 | 3,620 | +80 | +2.3% | 74,700 |
2018/02/06 | 3,590 | 3,590 | 3,440 | 3,540 | -210 | -5.6% | 95,600 |
2018/02/05 | 3,710 | 3,825 | 3,690 | 3,750 | -30 | -0.8% | 60,800 |
2018/02/02 | 3,795 | 3,805 | 3,725 | 3,780 | +40 | +1.1% | 55,700 |
2018/02/01 | 3,690 | 3,815 | 3,685 | 3,740 | +70 | +1.9% | 72,700 |
2018/01/31 | 3,705 | 3,750 | 3,660 | 3,670 | -70 | -1.9% | 83,000 |
2018/01/30 | 3,695 | 3,775 | 3,695 | 3,740 | -10 | -0.3% | 114,200 |
2018/01/29 | 3,920 | 3,945 | 3,735 | 3,750 | +320 | +9.3% | 155,800 |
2018/01/26 | 3,460 | 3,510 | 3,425 | 3,430 | -15 | -0.4% | 27,900 |
2018/01/25 | 3,520 | 3,520 | 3,425 | 3,445 | -40 | -1.1% | 24,600 |
2018/01/24 | 3,475 | 3,520 | 3,475 | 3,485 | +15 | +0.4% | 20,300 |
2018/01/23 | 3,580 | 3,650 | 3,465 | 3,470 | -70 | -2% | 42,000 |
2018/01/22 | 3,470 | 3,545 | 3,455 | 3,540 | +100 | +2.9% | 37,000 |
2018/01/19 | 3,365 | 3,480 | 3,355 | 3,440 | +80 | +2.4% | 22,000 |
2018/01/18 | 3,445 | 3,455 | 3,350 | 3,360 | -50 | -1.5% | 41,100 |
2018/01/17 | 3,485 | 3,500 | 3,370 | 3,410 | -40 | -1.2% | 37,800 |
2018/01/16 | 3,550 | 3,605 | 3,430 | 3,450 | -70 | -2% | 54,200 |
2018/01/15 | 3,300 | 3,550 | 3,280 | 3,520 | +360 | +11.4% | 127,200 |
2018/01/12 | 3,100 | 3,175 | 3,095 | 3,160 | +20 | +0.6% | 31,500 |
2018/01/11 | 3,165 | 3,175 | 3,095 | 3,140 | -20 | -0.6% | 38,400 |
2018/01/10 | 3,140 | 3,170 | 3,120 | 3,160 | +15 | +0.5% | 24,400 |
2018/01/09 | 3,215 | 3,230 | 3,120 | 3,145 | -45 | -1.4% | 32,700 |
2018/01/05 | 3,240 | 3,260 | 3,175 | 3,190 | -40 | -1.2% | 27,800 |
2018/01/04 | 3,185 | 3,245 | 3,175 | 3,230 | +40 | +1.3% | 31,500 |
2017/12/29 | 3,255 | 3,255 | 3,175 | 3,190 | -65 | -2% | 21,700 |
2017/12/28 | 3,240 | 3,280 | 3,240 | 3,255 | +20 | +0.6% | 18,600 |
2017/12/27 | 3,245 | 3,270 | 3,225 | 3,235 | -5 | -0.2% | 15,200 |
2017/12/26 | 3,235 | 3,280 | 3,230 | 3,240 | +10 | +0.3% | 16,100 |
2017/12/25 | 3,240 | 3,245 | 3,205 | 3,230 | -15 | -0.5% | 15,800 |
1751~
1800
件表示中 / 3704件
類似銘柄と比較する
現在ご覧いただいている「ダイト」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ダイト | 200,500円 | +4.5% | -33.7% | 3.49% | 20.04倍 | 0.58倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック(後発医薬品)メーカー向け強い |
ヘリオス | 32,000円 | +150.0% | - | 0.00% | - | 15.74倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
富士製薬 | 125,600円 | +15.7% | +5.3% | 3.62% | 9.08倍 | 0.67倍 |
|
女性医療、急性期医療の2領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
ミズホメディ | 149,300円 | +1.2% | -13.9% | 5.69% | 8.80倍 | 1.64倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
扶桑薬 | 225,800円 | +1.6% | -12.7% | 3.99% | 8.38倍 | 0.49倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
市場注目の銘柄
チャート関連のコラム